About Olema Oncology Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and ...

AI and Medical Technology company Echo IQ (“the Company” or “Echo IQ”) (ASX: EIQ), today announced that Dustin Haines, Chief Executive Officer, will participate in a fireside chat at the upcoming ...

Dr. Mark Ashley, honored as National Luminary of the Year, joins fellow industry leaders at the Brain Injury Association of America (BIAA) Luminary Event: (L–R) Dr. Brent Masel, BIAA National Medical ...

The research study evaluating Bucillamine remains in progress, and the Company is awaiting the final findings, which will be released only with the express authorization of DRDC. Revive will continue ...

Platform-triggered SMS engagement delivers a 98% open rate and achieves actionable patient responses within 90 seconds—nearly 60x faster than email or phone outreach—a finding confirmed in 2025 ...

8th Annual Evercore Healthcare Conference Wednesday, December 3, 2025, at 8:20 A.M. Eastern Time (ET) Piper Sandler 37th Annual Healthcare Conference Wednesday, December 3, 2025, at 11:00 A.M. Eastern ...

The 8 th Annual Evercore Healthcare Conference Format: Fireside Chat Host: Jonathan Miller Date and Time: Tuesday, December 2, 2025; 4:15 pm - 4:35 PM EST. Location: Sevilla A, Track 2, the Loews ...

Investors interested in arranging a meeting with company management during the conference should contact the Piper Sandler conference coordinator. A live audio webcast of the presentation can be ...

SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a majority-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido ® is a registered ...

Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common ...

The live conference call webcast will be accessible in the Investors section of the Company’s web site and directly via the following link: For those who cannot listen to the live broadcast, an online ...

In November 2025, the Company completed a public offering in the United States of 44,805,193 American Depositary Shares (“ADSs”) for aggregate gross proceeds of approximately €149 million (€139.3 ...